| JAK2 Exon 12 Mutations in Polycythemia Vera and Idiopathic Erythrocytosis LM Scott, W Tong, RL Levine, MA Scott, PA Beer, MR Stratton, PA Futreal, ... New England Journal of Medicine 356 (5), 459-468, 2007 | 1721 | 2007 |
| Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet T Barbui, G Barosi, G Birgegard, F Cervantes, G Finazzi, M Griesshammer, ... Journal of clinical oncology 29 (6), 761, 2011 | 1027 | 2011 |
| A comparison of low‐dose cytarabine and hydroxyurea with or without all‐trans retinoic acid for acute myeloid leukemia and high‐risk myelodysplastic syndrome in patients not … AK Burnett, D Milligan, AG Prentice, AH Goldstone, MF McMullin, RK Hills, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2007 | 749 | 2007 |
| Classification and personalized prognosis in myeloproliferative neoplasms J Grinfeld, J Nangalia, EJ Baxter, DC Wedge, N Angelopoulos, R Cantrill, ... New England Journal of Medicine 379 (15), 1416-1430, 2018 | 559 | 2018 |
| Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial AK Burnett, NH Russell, RK Hills, D Bowen, J Kell, S Knapper, YG Morgan, ... The lancet oncology 16 (13), 1295-1305, 2015 | 507 | 2015 |
| Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis. MF McMullin, D Bareford, P Campbell, AR Green, C Harrison, B Hunt, ... British journal of haematology 130 (2), 2005 | 469 | 2005 |
| A Gain-of-Function Mutation in the HIF2A Gene in Familial Erythrocytosis MJ Percy, PW Furlow, GS Lucas, X Li, TRJ Lappin, MF McMullin, FS Lee New England Journal of Medicine 358 (2), 162-168, 2008 | 403 | 2008 |
| Factors influencing success of clinical genome sequencing across a broad spectrum of disorders JC Taylor, HC Martin, S Lise, J Broxholme, JB Cazier, A Rimmer, ... Nature genetics 47 (7), 717-726, 2015 | 401 | 2015 |
| A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis MJ Percy, Q Zhao, A Flores, C Harrison, TRJ Lappin, PH Maxwell, ... Proceedings of the National Academy of Sciences 103 (3), 654-659, 2006 | 378 | 2006 |
| Guideline for investigation and management of adults and children presenting with a thrombocytosis. CN Harrison, D Bareford, N Butt, P Campbell, E Conneally, M Drummond, ... British journal of haematology 149 (3), 2010 | 355 | 2010 |
| Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations F Passamonti, C Elena, S Schnittger, RC Skoda, AR Green, F Girodon, ... Blood, The Journal of the American Society of Hematology 117 (10), 2813-2816, 2011 | 329 | 2011 |
| Two routes to leukemic transformation after a JAK2 mutation–positive myeloproliferative neoplasm PA Beer, F Delhommeau, JP LeCouédic, MA Dawson, E Chen, ... Blood, The Journal of the American Society of Hematology 115 (14), 2891-2900, 2010 | 328 | 2010 |
| Revised response criteria for polycythemia vera and essential thrombocythemia: an ELN and IWG-MRT consensus project G Barosi, R Mesa, G Finazzi, C Harrison, JJ Kiladjian, E Lengfelder, ... Blood, The Journal of the American Society of Hematology 121 (23), 4778-4781, 2013 | 323 | 2013 |
| Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference G Barosi, G Birgegard, G Finazzi, M Griesshammer, C Harrison, ... Blood, The Journal of the American Society of Hematology 113 (20), 4829-4833, 2009 | 313 | 2009 |
| A randomized comparison of daunorubicin 90 mg/m2 vs 60 mg/m2 in AML induction: results from the UK NCRI AML17 trial in 1206 patients AK Burnett, NH Russell, RK Hills, J Kell, J Cavenagh, L Kjeldsen, ... Blood, The Journal of the American Society of Hematology 125 (25), 3878-3885, 2015 | 298 | 2015 |
| How common are myeloproliferative neoplasms? A systematic review and meta‐analysis GJ Titmarsh, AS Duncombe, MF McMullin, M O'Rorke, R Mesa, ... American journal of hematology 89 (6), 581-587, 2014 | 264 | 2014 |
| Attempts to optimize induction and consolidation treatment in acute myeloid leukemia: results of the MRC AML12 trial AK Burnett, RK Hills, DW Milligan, AH Goldstone, AG Prentice, ... J Clin Oncol 28 (4), 586-595, 2010 | 260 | 2010 |
| Mutation of von Hippel–Lindau tumour suppressor and human cardiopulmonary physiology TG Smith, JT Brooks, GM Balanos, TR Lappin, DM Layton, DL Leedham, ... PLoS medicine 3 (7), e290, 2006 | 216 | 2006 |
| Regulation of human metabolism by hypoxia-inducible factor F Formenti, D Constantin-Teodosiu, Y Emmanuel, J Cheeseman, ... Proceedings of the National Academy of Sciences 107 (28), 12722-12727, 2010 | 206 | 2010 |
| A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove MJ Percy, PW Furlow, PA Beer, TRJ Lappin, MF McMullin, FS Lee Blood, The Journal of the American Society of Hematology 110 (6), 2193-2196, 2007 | 191 | 2007 |
